UTHRvs its industry peers
A metric-by-metric comparison of UTHR against iShares Biotechnology ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UTHRThis | — | — | — | — | 10.6%#1 | 11.7%#4 | 46.9%#1 | 22.6%#3 | — | — | — | — |
| VRTX | — | — | — | — | 8.9%#3 | 838.1%#2 | 34.8%#2 | 20.4%#4 | 25.4%#1 | — | 4.4%#2 | — |
| GILD | — | — | — | — | 2.4%#4 | 1672.9%#1 | 34.0%#3 | 36.2%#2 | 21.6%#2 | — | — | — |
| AMGN | — | — | — | — | 10.0%#2 | 88.5%#3 | 24.7%#6 | 83.9%#1 | 15.3%#3 | — | 33.8%#1 | — |
| REGN | — | — | — | — | 1.0%#6 | 2.1%#5 | 24.9%#5 | 14.2%#5 | 9.4%#5 | — | — | — |
| BIIB | — | — | — | — | 2.2%#5 | -20.8%#6 | 28.7%#4 | 8.7%#6 | 13.0%#4 | 4#1 | — | — |
Peer set: top holdings of IBB (iShares Biotechnology ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-08-01.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice